Roivant Sciences Ltd. (NASDAQ:ROIV) is one of the best stocks to buy under $20. On September 17, Roivant and Priovant Therapeutics announced positive results from the Phase 3 VALOR study, a 52-week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results